These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii. Saribas Z; Yurdakul P; Cetin-Hazirolan G; Arikan-Akdagli S Mycoses; 2012 Mar; 55(2):156-60. PubMed ID: 21668525 [TBL] [Abstract][Full Text] [Related]
7. Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics. Lewis JS Med Mycol; 2009; 47 Suppl 1():S376-81. PubMed ID: 19296368 [TBL] [Abstract][Full Text] [Related]
8. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species. Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416 [TBL] [Abstract][Full Text] [Related]
9. The echinocandins. Cappelletty D; Eiselstein-McKitrick K Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antifungal activity of ASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition. Morikawa H; Tomishima M; Kayakiri N; Araki T; Barrett D; Akamatsu S; Matsumoto S; Uchida S; Nakai T; Takeda S; Maki K Bioorg Med Chem Lett; 2014 Feb; 24(4):1172-5. PubMed ID: 24468413 [TBL] [Abstract][Full Text] [Related]
11. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan. Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422 [TBL] [Abstract][Full Text] [Related]
13. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713 [TBL] [Abstract][Full Text] [Related]
14. Echinocandin resistance in human pathogenic fungi. Munro CA Expert Rev Anti Infect Ther; 2012 Feb; 10(2):115-6. PubMed ID: 22339184 [No Abstract] [Full Text] [Related]
15. Echinocandins: the newest class of antifungals. Sucher AJ; Chahine EB; Balcer HE Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014 [TBL] [Abstract][Full Text] [Related]
16. The echinocandins: three useful choices or three too many? Bal AM Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413 [TBL] [Abstract][Full Text] [Related]
17. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Fera MT; La Camera E; De Sarro A Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707 [TBL] [Abstract][Full Text] [Related]